Streetbeat News

Stock Prices

BABA

Alibaba's shares are trading higher following the company's Q1 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:12 pm

GDRX

DA Davidson analyst Robert Simmons has upgraded GoodRx Holdings (NASDAQ:GDRX) from Neutral to Buy and announced a price target of $9.5.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:10 pm

NLCP

NewLake Capital Partners, Inc. (OCTQX:NLCP) reported Q2 2023 revenue of $11.4 million, up 8.2% YoY. Net income attributable to common stockholders was $5.8 million, up from $3.8 million in Q2 2022. The company maintained its quarterly dividend of $0.39 per share and repurchased 105,679 shares in the first half of the year. NewLake Capital is providing AFFO guidance for full year 2023 of $39.8 to $40.8 million.

Portfolio Pulse from Vuk Zdinjak

August 10, 2023 | 12:09 pm

URGN

UroGen Pharma Ltd has reiterated its FY23 revenue forecast to be between $76M and $86M, which is slightly below the estimated $80.74M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:07 pm

AMRS

APP

CPRI

GRTX

AppLovin Corporation's shares rose by 22.6% in pre-market trading following better-than-expected Q2 results. Capri Holdings Limited's shares also rose by 26.8% as Tapestry is reportedly nearing a deal to buy the company. On the other hand, Amyris, Inc.'s shares fell by 56.2% after the company filed for bankruptcy, and Galera Therapeutics, Inc.'s shares fell by 81.7% after receiving a Complete Response Letter from the U.S. FDA.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 12:06 pm

RELI

Reliance Global Group (NASDAQ:RELI) reported Q2 losses of $(2.77) per share, missing the analyst consensus estimate of $(0.70) by 295.71%. This is a 84.67% decrease over losses of $(1.50) per share from the same period last year. However, the company reported quarterly sales of $3.93 million, beating the analyst consensus estimate of $3.60 million by 9.17%. This is a 6.58% decrease over sales of $4.21 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:05 pm

IPSC

Century Therapeutics (NASDAQ:IPSC) reported weaker-than-expected Q2 results, with a loss of 56 cents per share and sales of $99,000, missing estimates. Following the announcement, Chardan Capital, HC Wainwright & Co., and EF Hutton revised their price targets for the company's shares.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 12:05 pm

ISUN

iSun has reiterated its FY23 revenue guidance in the range of $95M-$100M, which is in line with the estimated $97.01M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:05 pm

PFIN

P & F Industries reported Q2 earnings of $0.07 per share, an 800% increase YoY. However, sales decreased by 9.25% to $16.16M compared to $17.81M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:05 pm

RL

Ralph Lauren has projected its Q2 2024 revenue to be flat or slightly up compared to last year in constant currency. The company also expects its Q2 2024 operating margin to be between 9.5% and 10%.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:03 pm